ETFs positioned on DocMorris AG

Name YTD change Weight AuM
+11.17% - 41,780 M€
+8.11% - 5,871 M€
+16.04% - 3,265 M€
+0.76% - 51 M€
+3.58% - 49 M€
-4.23%0.83% 128 M€
+9.08%0.08% 797 M€
+6.19%0.04% 918 M€
+3.31%0.02% 12,001 M€
+13.55%0.02% 2,460 M€
+15.41%0.02% 517 M€
+15.49%0.01% 6 M€
+13.44%0.01% 7,239 M€
+5.46%0.01% 742 M€
+6.55%0.01% 1,193 M€
+12.42%0.01% 9,865 M€
-.--%0% 3 M€
+7.78%0% 0 M€
+0.48%0% 7 M€
+12.04%0% 1,674 M€
+13.85%0% 39 M€
+8.73%0% 32,566 M€
+4.71%0% 317 M€
+15.34%0% 12,086 M€
+14.95%0% 1,199 M€
+11.05%0% 576 M€
+1.39%0% 1,110 M€
+10.29%0% 67 M€
+10.89%0% 19 M€
+8.06%0% 4,204 M€
-.--%0% 73 M€
+11.87%0% 62 M€
+0.07%0% 18 M€
+6.39%0% 1,021 M€
+3.68%0% 37 M€
0.00%-0% 12 M€
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337